Abstract: Global Inferior Vena Cava (IVC) Filters Market to Reach $1. 1 Billion by 2026 . - Inferior vena cava filters are vascular filters intended to be implanted into inferior vena cava for preventing life-threatening pulmonary embolism (PE).

New York, June 25, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Inferior Vena Cava (IVC) Filters Industry" - https://www.reportlinker.com/p05798884/?utm_source=GNW
Growth in the market is set to be fueled by rising incidence of cardiovascular conditions and robust demand for minimally-invasive techniques. The inferior vena cava filters market is bolstered by rising cases of VTE or PE as a result of increasing aging population, sedentary lifestyles and lifestyle-related conditions. These factors are creating high demand for retrievable or optional filters along with approaches to effectively place and retrieve these filters. The market growth is also buoyed by increasing preference for minimally-invasive surgeries, mainly for cardiovascular conditions, and favorable reimbursement policies in both developed and developing regions. The inferior vena cava filters market is also benefitting from advances in healthcare technology and introduction of sophisticated devices including convertible, combination and bio-convertible filters as well as central venous catheters.

- Amid the COVID-19 crisis, the global market for Inferior Vena Cava (IVC) Filters estimated at US$683.5 Million in the year 2020, is projected to reach a revised size of US$1.1 Billion by 2026, growing at a CAGR of 8.1% over the analysis period. Retrievable, one of the segments analyzed in the report, is projected to grow at a 8.5% CAGR to reach US$772.5 Million by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Permanent segment is readjusted to a revised 7.2% CAGR for the next 7-year period. This segment currently accounts for a 36.2% share of the global Inferior Vena Cava (IVC) Filters market. The availability of optional or retrievable filters, in particular, has increased filter placement rates as well as spurred the expansion of indications for filter placement. The number of filter placements has witnessed a steady increase in the US. Growth in the permanent inferior vena cava filters segment is due to cost-effectiveness of these devices and rising cases of venous thromboembolism (VTE). These filters are suitable options for patients requiring lifelong protection owing to their efficiency and lower risk. The segment is also poised to benefit from availability of advanced retrieval techniques to remove these filters.

The U.S. Market is Estimated at $290.4 Million in 2021, While China is Forecast to Reach $111.4 Million by 2026

- The Inferior Vena Cava (IVC) Filters market in the U.S. is estimated at US$290.4 Million in the year 2021. The country currently accounts for a 39.74% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$111.4 Million in the year 2026 trailing a CAGR of 10.2% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.3% and 7.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR while Rest of European market (as defined in the study) will reach US$122.5 Million by the end of the analysis period. The US market is driven by considerably high healthcare expenditure, and increasing adoption of advanced technology, robust healthcare infrastructure, presence of leading players and investments in R&D for finding new treatments for cardiovascular conditions. Growth in the European region is being driven by rising cases of pulmonary emboli (PE), increasing aging population, high healthcare spending and growing acceptance of advanced filters. Improvement in healthcare infrastructure, large number of related patients, and continuously growing healthcare expenditure augment demand for IVC filters in the Asia-Pacific region.
Select Competitors (Total 10 Featured)

• Argon Medical Devices, Inc.

• B. Braun Melsungen AG

• BARD, A Becton, Dickinson Company

• Boston Scientific Corporation

• Cook Medical, Inc.

Read the full report: https://www.reportlinker.com/p05798884/?utm_source=GNW

CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
2020 Marked as a Year of Disruption & Transformation
EXHIBIT 1: World Economic Growth Projections (Real GDP, Annual
% Change) for 2019 to 2022
Medical Equipment & Supplies Market COVID-19 Impact, Market
Reset & the New Normal
COVID-19 Impact: Inferior Vena Cava Market to Regain Momentum
after Brief Hiatus
Rising Prevalence of Cardiovascular Conditions Drives Inferior
Vena Cava Filters Market
Retrievable Inferior Vena Ceva Filters Constitute the Largest
Segment
Select FDA Approved Retrievable IVC Filters
Permanent Filters Hold a Significant Share
Select FDA Approved Permanent IVC Filters
The US Holds Commanding Position in Global Inferior Vena Cava
Filters Market
Developing Regions to Present Increased Growth Opportunities
Hospitals Account for an Enviable Market Share
End-use Analysis
Competitive Landscape
EXHIBIT 2: Market Share of Leading Players in Global Inferior
Vena Cava Filter Market: 2019
Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
Rising Incidence of Deep Vein Thrombosis Drive Demand for
Inferior Vena Cava Filters
Increasing Incidence of Pulmonary Embolism Spurs Need for
Inferior Vena Cava Filters
Growing Demand for Minimally Invasive Surgeries Propels Market
Growth
Growing Aging Population Bodes Well for Inferior Vena Cava
Filters Market Growth
EXHIBIT 3: Expanding Elderly Population Worldwide: Breakdown of
Number of People Aged 65+ Years in Million by Geographic
Region for the Years 2019 and 2030
EXHIBIT 4: Life Expectancy at Birth for Select Countries in
Number of Years
Rising Incidence of Cardiovascular Diseases Propels the Demand
for Inferior Vena Cava Filters Market
EXHIBIT 5: Global Annual Medical Cost of CVD in US$ Billion:
2010, 2015, 2020, 2025 and 2030
EXHIBIT 6: Fatalities by Heart Conditions: Estimated Percentage
Breakdown for Cardiovascular Disease, Ischemic Heart Disease,
Stroke, and Others
Expanding Indications for IVC Filters
Significant Decrease in IVC Filter Implantations post FDA
Safety Communication
Innovative Approaches for IVC Filter Placements/Retrievals
Technological Advances to Buoy Installations
Expensive Nature of Devices & Low Awareness Inhibit Growth

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Inferior Vena Cava
(IVC) Filters by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Inferior Vena Cava (IVC)
Filters by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2015 through 2019 and % CAGR

Table 3: World 12-Year Perspective for Inferior Vena Cava (IVC)
Filters by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa Markets for Years 2015,
2020 & 2027

Table 4: World Current & Future Analysis for Retrievable by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 5: World Historic Review for Retrievable by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2015 through 2019 and
% CAGR

Table 6: World 12-Year Perspective for Retrievable by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2015, 2020 & 2027

Table 7: World Current & Future Analysis for Permanent by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 8: World Historic Review for Permanent by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2015 through 2019 and
% CAGR

Table 9: World 12-Year Perspective for Permanent by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2015, 2020 & 2027

Table 10: World Current & Future Analysis for Treatment of
Venous Thromboembolism by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Treatment of Venous
Thromboembolism by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2015 through 2019 and % CAGR

Table 12: World 12-Year Perspective for Treatment of Venous
Thromboembolism by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2015, 2020 & 2027

Table 13: World Current & Future Analysis for Prevention of
Pulmonary Embolism by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Prevention of Pulmonary
Embolism by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2015 through 2019 and % CAGR

Table 15: World 12-Year Perspective for Prevention of Pulmonary
Embolism by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2015, 2020 &
2027

III. MARKET ANALYSIS

UNITED STATES
Table 16: USA Current & Future Analysis for Inferior Vena Cava
(IVC) Filters by Segment - Retrievable and Permanent -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 17: USA Historic Review for Inferior Vena Cava (IVC)
Filters by Segment - Retrievable and Permanent Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR

Table 18: USA 12-Year Perspective for Inferior Vena Cava (IVC)
Filters by Segment - Percentage Breakdown of Value Sales for
Retrievable and Permanent for the Years 2015, 2020 & 2027

Table 19: USA Current & Future Analysis for Inferior Vena Cava
(IVC) Filters by Application - Treatment of Venous
Thromboembolism and Prevention of Pulmonary Embolism -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 20: USA Historic Review for Inferior Vena Cava (IVC)
Filters by Application - Treatment of Venous Thromboembolism
and Prevention of Pulmonary Embolism Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2015 through
2019 and % CAGR

Table 21: USA 12-Year Perspective for Inferior Vena Cava (IVC)
Filters by Application - Percentage Breakdown of Value Sales
for Treatment of Venous Thromboembolism and Prevention of
Pulmonary Embolism for the Years 2015, 2020 & 2027

CANADA
Table 22: Canada Current & Future Analysis for Inferior Vena
Cava (IVC) Filters by Segment - Retrievable and Permanent -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 23: Canada Historic Review for Inferior Vena Cava (IVC)
Filters by Segment - Retrievable and Permanent Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR

Table 24: Canada 12-Year Perspective for Inferior Vena Cava
(IVC) Filters by Segment - Percentage Breakdown of Value Sales
for Retrievable and Permanent for the Years 2015, 2020 & 2027

Table 25: Canada Current & Future Analysis for Inferior Vena
Cava (IVC) Filters by Application - Treatment of Venous
Thromboembolism and Prevention of Pulmonary Embolism -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 26: Canada Historic Review for Inferior Vena Cava (IVC)
Filters by Application - Treatment of Venous Thromboembolism
and Prevention of Pulmonary Embolism Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2015 through
2019 and % CAGR

Table 27: Canada 12-Year Perspective for Inferior Vena Cava
(IVC) Filters by Application - Percentage Breakdown of Value
Sales for Treatment of Venous Thromboembolism and Prevention of
Pulmonary Embolism for the Years 2015, 2020 & 2027

JAPAN
Table 28: Japan Current & Future Analysis for Inferior Vena
Cava (IVC) Filters by Segment - Retrievable and Permanent -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 29: Japan Historic Review for Inferior Vena Cava (IVC)
Filters by Segment - Retrievable and Permanent Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR

Table 30: Japan 12-Year Perspective for Inferior Vena Cava
(IVC) Filters by Segment - Percentage Breakdown of Value Sales
for Retrievable and Permanent for the Years 2015, 2020 & 2027

Table 31: Japan Current & Future Analysis for Inferior Vena
Cava (IVC) Filters by Application - Treatment of Venous
Thromboembolism and Prevention of Pulmonary Embolism -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 32: Japan Historic Review for Inferior Vena Cava (IVC)
Filters by Application - Treatment of Venous Thromboembolism
and Prevention of Pulmonary Embolism Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2015 through
2019 and % CAGR

Table 33: Japan 12-Year Perspective for Inferior Vena Cava
(IVC) Filters by Application - Percentage Breakdown of Value
Sales for Treatment of Venous Thromboembolism and Prevention of
Pulmonary Embolism for the Years 2015, 2020 & 2027

CHINA
Table 34: China Current & Future Analysis for Inferior Vena
Cava (IVC) Filters by Segment - Retrievable and Permanent -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 35: China Historic Review for Inferior Vena Cava (IVC)
Filters by Segment - Retrievable and Permanent Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR

Table 36: China 12-Year Perspective for Inferior Vena Cava
(IVC) Filters by Segment - Percentage Breakdown of Value Sales
for Retrievable and Permanent for the Years 2015, 2020 & 2027

Table 37: China Current & Future Analysis for Inferior Vena
Cava (IVC) Filters by Application - Treatment of Venous
Thromboembolism and Prevention of Pulmonary Embolism -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 38: China Historic Review for Inferior Vena Cava (IVC)
Filters by Application - Treatment of Venous Thromboembolism
and Prevention of Pulmonary Embolism Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2015 through
2019 and % CAGR

Table 39: China 12-Year Perspective for Inferior Vena Cava
(IVC) Filters by Application - Percentage Breakdown of Value
Sales for Treatment of Venous Thromboembolism and Prevention of
Pulmonary Embolism for the Years 2015, 2020 & 2027

EUROPE
Table 40: Europe Current & Future Analysis for Inferior Vena
Cava (IVC) Filters by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 41: Europe Historic Review for Inferior Vena Cava (IVC)
Filters by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2015 through 2019 and
% CAGR

Table 42: Europe 12-Year Perspective for Inferior Vena Cava
(IVC) Filters by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK, Spain, Russia and
Rest of Europe Markets for Years 2015, 2020 & 2027

Table 43: Europe Current & Future Analysis for Inferior Vena
Cava (IVC) Filters by Segment - Retrievable and Permanent -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 44: Europe Historic Review for Inferior Vena Cava (IVC)
Filters by Segment - Retrievable and Permanent Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR

Table 45: Europe 12-Year Perspective for Inferior Vena Cava
(IVC) Filters by Segment - Percentage Breakdown of Value Sales
for Retrievable and Permanent for the Years 2015, 2020 & 2027

Table 46: Europe Current & Future Analysis for Inferior Vena
Cava (IVC) Filters by Application - Treatment of Venous
Thromboembolism and Prevention of Pulmonary Embolism -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 47: Europe Historic Review for Inferior Vena Cava (IVC)
Filters by Application - Treatment of Venous Thromboembolism
and Prevention of Pulmonary Embolism Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2015 through
2019 and % CAGR

Table 48: Europe 12-Year Perspective for Inferior Vena Cava
(IVC) Filters by Application - Percentage Breakdown of Value
Sales for Treatment of Venous Thromboembolism and Prevention of
Pulmonary Embolism for the Years 2015, 2020 & 2027

FRANCE
Table 49: France Current & Future Analysis for Inferior Vena
Cava (IVC) Filters by Segment - Retrievable and Permanent -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 50: France Historic Review for Inferior Vena Cava (IVC)
Filters by Segment - Retrievable and Permanent Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR

Table 51: France 12-Year Perspective for Inferior Vena Cava
(IVC) Filters by Segment - Percentage Breakdown of Value Sales
for Retrievable and Permanent for the Years 2015, 2020 & 2027

Table 52: France Current & Future Analysis for Inferior Vena
Cava (IVC) Filters by Application - Treatment of Venous
Thromboembolism and Prevention of Pulmonary Embolism -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 53: France Historic Review for Inferior Vena Cava (IVC)
Filters by Application - Treatment of Venous Thromboembolism
and Prevention of Pulmonary Embolism Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2015 through
2019 and % CAGR

Table 54: France 12-Year Perspective for Inferior Vena Cava
(IVC) Filters by Application - Percentage Breakdown of Value
Sales for Treatment of Venous Thromboembolism and Prevention of
Pulmonary Embolism for the Years 2015, 2020 & 2027

GERMANY
Table 55: Germany Current & Future Analysis for Inferior Vena
Cava (IVC) Filters by Segment - Retrievable and Permanent -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 56: Germany Historic Review for Inferior Vena Cava (IVC)
Filters by Segment - Retrievable and Permanent Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR

Table 57: Germany 12-Year Perspective for Inferior Vena Cava
(IVC) Filters by Segment - Percentage Breakdown of Value Sales
for Retrievable and Permanent for the Years 2015, 2020 & 2027

Table 58: Germany Current & Future Analysis for Inferior Vena
Cava (IVC) Filters by Application - Treatment of Venous
Thromboembolism and Prevention of Pulmonary Embolism -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 59: Germany Historic Review for Inferior Vena Cava (IVC)
Filters by Application - Treatment of Venous Thromboembolism
and Prevention of Pulmonary Embolism Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2015 through
2019 and % CAGR

Table 60: Germany 12-Year Perspective for Inferior Vena Cava
(IVC) Filters by Application - Percentage Breakdown of Value
Sales for Treatment of Venous Thromboembolism and Prevention of
Pulmonary Embolism for the Years 2015, 2020 & 2027

ITALY
Table 61: Italy Current & Future Analysis for Inferior Vena
Cava (IVC) Filters by Segment - Retrievable and Permanent -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 62: Italy Historic Review for Inferior Vena Cava (IVC)
Filters by Segment - Retrievable and Permanent Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR

Table 63: Italy 12-Year Perspective for Inferior Vena Cava
(IVC) Filters by Segment - Percentage Breakdown of Value Sales
for Retrievable and Permanent for the Years 2015, 2020 & 2027

Table 64: Italy Current & Future Analysis for Inferior Vena
Cava (IVC) Filters by Application - Treatment of Venous
Thromboembolism and Prevention of Pulmonary Embolism -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 65: Italy Historic Review for Inferior Vena Cava (IVC)
Filters by Application - Treatment of Venous Thromboembolism
and Prevention of Pulmonary Embolism Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2015 through
2019 and % CAGR

Table 66: Italy 12-Year Perspective for Inferior Vena Cava
(IVC) Filters by Application - Percentage Breakdown of Value
Sales for Treatment of Venous Thromboembolism and Prevention of
Pulmonary Embolism for the Years 2015, 2020 & 2027

UNITED KINGDOM
Table 67: UK Current & Future Analysis for Inferior Vena Cava
(IVC) Filters by Segment - Retrievable and Permanent -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 68: UK Historic Review for Inferior Vena Cava (IVC)
Filters by Segment - Retrievable and Permanent Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR

Table 69: UK 12-Year Perspective for Inferior Vena Cava (IVC)
Filters by Segment - Percentage Breakdown of Value Sales for
Retrievable and Permanent for the Years 2015, 2020 & 2027

Table 70: UK Current & Future Analysis for Inferior Vena Cava
(IVC) Filters by Application - Treatment of Venous
Thromboembolism and Prevention of Pulmonary Embolism -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 71: UK Historic Review for Inferior Vena Cava (IVC)
Filters by Application - Treatment of Venous Thromboembolism
and Prevention of Pulmonary Embolism Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2015 through
2019 and % CAGR

Table 72: UK 12-Year Perspective for Inferior Vena Cava (IVC)
Filters by Application - Percentage Breakdown of Value Sales
for Treatment of Venous Thromboembolism and Prevention of
Pulmonary Embolism for the Years 2015, 2020 & 2027

SPAIN
Table 73: Spain Current & Future Analysis for Inferior Vena
Cava (IVC) Filters by Segment - Retrievable and Permanent -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 74: Spain Historic Review for Inferior Vena Cava (IVC)
Filters by Segment - Retrievable and Permanent Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR

Table 75: Spain 12-Year Perspective for Inferior Vena Cava
(IVC) Filters by Segment - Percentage Breakdown of Value Sales
for Retrievable and Permanent for the Years 2015, 2020 & 2027

Table 76: Spain Current & Future Analysis for Inferior Vena
Cava (IVC) Filters by Application - Treatment of Venous
Thromboembolism and Prevention of Pulmonary Embolism -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 77: Spain Historic Review for Inferior Vena Cava (IVC)
Filters by Application - Treatment of Venous Thromboembolism
and Prevention of Pulmonary Embolism Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2015 through
2019 and % CAGR

Table 78: Spain 12-Year Perspective for Inferior Vena Cava
(IVC) Filters by Application - Percentage Breakdown of Value
Sales for Treatment of Venous Thromboembolism and Prevention of
Pulmonary Embolism for the Years 2015, 2020 & 2027

RUSSIA
Table 79: Russia Current & Future Analysis for Inferior Vena
Cava (IVC) Filters by Segment - Retrievable and Permanent -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 80: Russia Historic Review for Inferior Vena Cava (IVC)
Filters by Segment - Retrievable and Permanent Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR

Table 81: Russia 12-Year Perspective for Inferior Vena Cava
(IVC) Filters by Segment - Percentage Breakdown of Value Sales
for Retrievable and Permanent for the Years 2015, 2020 & 2027

Table 82: Russia Current & Future Analysis for Inferior Vena
Cava (IVC) Filters by Application - Treatment of Venous
Thromboembolism and Prevention of Pulmonary Embolism -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 83: Russia Historic Review for Inferior Vena Cava (IVC)
Filters by Application - Treatment of Venous Thromboembolism
and Prevention of Pulmonary Embolism Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2015 through
2019 and % CAGR

Table 84: Russia 12-Year Perspective for Inferior Vena Cava
(IVC) Filters by Application - Percentage Breakdown of Value
Sales for Treatment of Venous Thromboembolism and Prevention of
Pulmonary Embolism for the Years 2015, 2020 & 2027

REST OF EUROPE
Table 85: Rest of Europe Current & Future Analysis for Inferior
Vena Cava (IVC) Filters by Segment - Retrievable and Permanent -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 86: Rest of Europe Historic Review for Inferior Vena Cava
(IVC) Filters by Segment - Retrievable and Permanent Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR

Table 87: Rest of Europe 12-Year Perspective for Inferior Vena
Cava (IVC) Filters by Segment - Percentage Breakdown of Value
Sales for Retrievable and Permanent for the Years 2015, 2020 &
2027

Table 88: Rest of Europe Current & Future Analysis for Inferior
Vena Cava (IVC) Filters by Application - Treatment of Venous
Thromboembolism and Prevention of Pulmonary Embolism -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 89: Rest of Europe Historic Review for Inferior Vena Cava
(IVC) Filters by Application - Treatment of Venous
Thromboembolism and Prevention of Pulmonary Embolism Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR

Table 90: Rest of Europe 12-Year Perspective for Inferior Vena
Cava (IVC) Filters by Application - Percentage Breakdown of
Value Sales for Treatment of Venous Thromboembolism and
Prevention of Pulmonary Embolism for the Years 2015, 2020 &
2027

ASIA-PACIFIC
Table 91: Asia-Pacific Current & Future Analysis for Inferior
Vena Cava (IVC) Filters by Geographic Region - Australia,
India, South Korea and Rest of Asia-Pacific Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 92: Asia-Pacific Historic Review for Inferior Vena Cava
(IVC) Filters by Geographic Region - Australia, India, South
Korea and Rest of Asia-Pacific Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2015 through 2019 and
% CAGR

Table 93: Asia-Pacific 12-Year Perspective for Inferior Vena
Cava (IVC) Filters by Geographic Region - Percentage Breakdown
of Value Sales for Australia, India, South Korea and Rest of
Asia-Pacific Markets for Years 2015, 2020 & 2027

Table 94: Asia-Pacific Current & Future Analysis for Inferior
Vena Cava (IVC) Filters by Segment - Retrievable and Permanent -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 95: Asia-Pacific Historic Review for Inferior Vena Cava
(IVC) Filters by Segment - Retrievable and Permanent Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR

Table 96: Asia-Pacific 12-Year Perspective for Inferior Vena
Cava (IVC) Filters by Segment - Percentage Breakdown of Value
Sales for Retrievable and Permanent for the Years 2015, 2020 &
2027

Table 97: Asia-Pacific Current & Future Analysis for Inferior
Vena Cava (IVC) Filters by Application - Treatment of Venous
Thromboembolism and Prevention of Pulmonary Embolism -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 98: Asia-Pacific Historic Review for Inferior Vena Cava
(IVC) Filters by Application - Treatment of Venous
Thromboembolism and Prevention of Pulmonary Embolism Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR

Table 99: Asia-Pacific 12-Year Perspective for Inferior Vena
Cava (IVC) Filters by Application - Percentage Breakdown of
Value Sales for Treatment of Venous Thromboembolism and
Prevention of Pulmonary Embolism for the Years 2015, 2020 &
2027

AUSTRALIA
Table 100: Australia Current & Future Analysis for Inferior
Vena Cava (IVC) Filters by Segment - Retrievable and Permanent -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 101: Australia Historic Review for Inferior Vena Cava
(IVC) Filters by Segment - Retrievable and Permanent Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR

Table 102: Australia 12-Year Perspective for Inferior Vena Cava
(IVC) Filters by Segment - Percentage Breakdown of Value Sales
for Retrievable and Permanent for the Years 2015, 2020 & 2027

Table 103: Australia Current & Future Analysis for Inferior
Vena Cava (IVC) Filters by Application - Treatment of Venous
Thromboembolism and Prevention of Pulmonary Embolism -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 104: Australia Historic Review for Inferior Vena Cava
(IVC) Filters by Application - Treatment of Venous
Thromboembolism and Prevention of Pulmonary Embolism Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR

Table 105: Australia 12-Year Perspective for Inferior Vena Cava
(IVC) Filters by Application - Percentage Breakdown of Value
Sales for Treatment of Venous Thromboembolism and Prevention of
Pulmonary Embolism for the Years 2015, 2020 & 2027

INDIA
Table 106: India Current & Future Analysis for Inferior Vena
Cava (IVC) Filters by Segment - Retrievable and Permanent -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 107: India Historic Review for Inferior Vena Cava (IVC)
Filters by Segment - Retrievable and Permanent Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR

Table 108: India 12-Year Perspective for Inferior Vena Cava
(IVC) Filters by Segment - Percentage Breakdown of Value Sales
for Retrievable and Permanent for the Years 2015, 2020 & 2027

Table 109: India Current & Future Analysis for Inferior Vena
Cava (IVC) Filters by Application - Treatment of Venous
Thromboembolism
Read the full report: https://www.reportlinker.com/p05798884/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001